Mettler-Toledo International, Inc. (NYSE:MTD) Shares Bought by Crown Oak Advisors LLC

Crown Oak Advisors LLC boosted its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 5.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,942 shares of the medical instruments supplier's stock after purchasing an additional 298 shares during the quarter. Mettler-Toledo International comprises about 3.5% of Crown Oak Advisors LLC's investment portfolio, making the stock its 14th largest position. Crown Oak Advisors LLC's holdings in Mettler-Toledo International were worth $7,017,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Farther Finance Advisors LLC increased its position in Mettler-Toledo International by 14.3% during the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock valued at $78,000 after acquiring an additional 8 shares during the last quarter. Steward Partners Investment Advisory LLC increased its position in Mettler-Toledo International by 3.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock valued at $374,000 after acquiring an additional 9 shares during the last quarter. Atlantic Union Bankshares Corp increased its position in Mettler-Toledo International by 0.5% during the fourth quarter. Atlantic Union Bankshares Corp now owns 2,083 shares of the medical instruments supplier's stock valued at $2,549,000 after acquiring an additional 10 shares during the last quarter. Congress Asset Management Co. increased its position in Mettler-Toledo International by 1.8% during the first quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier's stock valued at $788,000 after acquiring an additional 12 shares during the last quarter. Finally, Torray Investment Partners LLC increased its position in Mettler-Toledo International by 1.0% during the fourth quarter. Torray Investment Partners LLC now owns 1,356 shares of the medical instruments supplier's stock valued at $1,659,000 after acquiring an additional 13 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Analyst Ratings Changes

MTD has been the topic of a number of analyst reports. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their price target for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a report on Tuesday, April 22nd. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a report on Monday, May 5th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a report on Monday, April 7th. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $1,302.11.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock traded up $9.33 during midday trading on Friday, hitting $1,154.80. 168,670 shares of the company's stock were exchanged, compared to its average volume of 152,159. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,546.93. The firm has a 50-day moving average of $1,118.58 and a two-hundred day moving average of $1,200.54. The company has a market cap of $24.00 billion, a PE ratio of 28.80, a P/E/G ratio of 3.42 and a beta of 1.38.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The company had revenue of $883.74 million for the quarter, compared to analysts' expectations of $876.61 million. During the same period in the prior year, the business earned $8.89 EPS. The firm's quarterly revenue was down 4.6% on a year-over-year basis. As a group, equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Activity

In other news, Director Michael A. Kelly sold 1,062 shares of the firm's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director now directly owns 120 shares in the company, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.